Description: The bioavailability of xenobiotics refers to the extent and rate at which a xenobiotic, which is any chemical substance not produced by the organism, is absorbed and becomes available at the site of action within an organism. This concept is crucial in pharmacology and toxicology, as it determines the efficacy and safety of chemical compounds, including drugs and environmental pollutants. Bioavailability can be influenced by various factors, such as the chemical form of the xenobiotic, the route of administration, the physiological characteristics of the receiving organism, and interactions with other compounds. For example, a xenobiotic administered intravenously will have a bioavailability of 100%, while one administered orally may have variable bioavailability due to metabolism in the liver and absorption in the gastrointestinal tract. Assessing bioavailability is essential for the development of new drugs, as it allows predictions about how a compound will behave in the human body and its potential to cause adverse effects. Additionally, in the environmental context, the bioavailability of xenobiotics can influence the toxicity of pollutants in ecosystems, affecting the health of organisms and environmental quality.